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Strychnine-sensitive glycine receptors (GlyRs) mediate syn-
aptic inhibition in the spinal cord, brainstem, and other regions
of the mammalian central nervous system. In this minireview,
we summarize our current view of the structure, ligand-binding
sites, and chloride channel of these receptors and discuss
recently emerging functions of distinct GlyR isoforms. GlyRs
not only regulate the excitability of motor and afferent sensory
neurons, including pain fibers, but also are involved in the pro-
cessing of visual and auditory signals. Hence, GlyRs constitute
promising targets for the development of therapeutically useful
compounds.
The normal functioning of the CNS depends on the balanced
interplay of both excitatory and inhibitory neurons. Glutamate
is the principal excitatory and GABA and glycine are the major
inhibitory neurotransmitters in the adult mammalian CNS.
Glycine serves, in addition, as a co-agonist of glutamate at the
NMDA subtype of excitatory glutamate receptors.
Glycinergic synapses mediate fast inhibitory neurotransmis-
sion mainly in the spinal cord, brainstem, and caudal brain and
control a variety of motor and sensory functions, including
vision and audition (1). Glycine exerts its inhibitory effects via
specific glycine receptors (GlyRs)2 that are highly enriched in
the postsynaptic membrane. Binding of glycine leads to the
opening of the GlyR integral anion channel, and the resulting
influx of Cl ions hyperpolarizes the postsynaptic cell, thereby
inhibiting neuronal firing. The alkaloid strychnine antagonizes
glycine binding with high affinity and has proven to be a unique
tool in radioligand binding studies (2) and affinity purification
(3) of GlyRs. Since these original studies, three decades of GlyR
research have generated a wealth of genetic, functional, and
structural data, which are summarized here.
Composition of GlyR Proteins
GlyRs are group I ligand-gated ion channels (LGICs) that
belong to the Cys loop receptor family, which, in addition,
includes nicotinic acetylcholine (nAChR), serotonin type 3
(5-HT3), and the closely related GABAA (GABAAR) receptors
(4, 5). Affinity-purified GlyR preparations contain three poly-
peptide species (3): the GlyR (48 kDa) and GlyR (58 kDa)
subunits and a tightly bound cytosolic scaffolding protein (93
kDa) later named gephyrin (6). Cross-linking experiments
showed that purified GlyRs are heteropentameric proteins,
similar to the nAChRs in Torpedo electric organ and skeletal
muscle (7). Their subunit stoichiometry was originally thought
to be 3:2 (7, 8), but more recently, this was revised to 2:3
(9, 10).
Molecular cloning identified four vertebrate genes (called
Glra1–4) encoding GlyR subunits (1–4) and a single gene
(Glrb) encoding theGlyR subunit (11–15). All GlyR subunits
display high sequence identity (80%) (supplemental Fig. S1)
and, upon heterologous expression, form functional homo-
meric glycine-gated channels with properties closely resem-
bling those of GlyRs in vivo (4, 5). By photoaffinity labeling with
[3H]strychnine, theGlyR subunits were shown to possess crit-
ical determinants of ligand binding (16). GlyR displays signif-
icant sequence differences compared with the  subunits
(50% identity) (supplemental Fig. S1) and does not generate
functional receptors when expressed alone (11) but is retained
in the endoplasmic reticulum (17).However, theGlyR subunit
is more than simply a structural subunit because it contributes
to agonist binding (9) and has an essential role in the intracel-
lular trafficking and synaptic clustering of postsynaptic GlyRs
(18, 19). Its extended cytoplasmic loop region binds to the post-
synaptic scaffolding protein gephyrin with high affinity (18, 20)
and interacts with Vps35 and neurobeachin, proteins impli-
cated in intracellular membrane protein transport (21).
The overall topology of GlyR subunits is shared with that of
other group I LGIC proteins (22). All of these polypeptides con-
tain a large N-terminal extracellular domain (ECD), four trans-
membrane segments (TM1–TM4), a long intracellular loop
connecting TM3 and TM4, and a short extracellular C termi-
nus. Sequence homologies are particularly high within the
transmembrane segments and a conserved disulfide-bonded
motif of 15 amino acids (“Cys loop”) located in the ECD.
Although the number of GlyR subunit genes (n 5) appears to
be modest compared with those found in the mammalian
nAChR (n  17) and GABAAR (n  20) families, alternative
splicing of exons encoding segments of the extracellular N-ter-
minal or intracellular loop regions further extends GlyR sub-
unit heterogeneity (4, 5, 23). In the case of GlyR2, splice vari-
ants in the ECD have been shown to differ in agonist efficacies
(24), and intracellular loop variants of GlyR3 have been found
to differ in receptor desensitization (25) and subcellular target-
ing (26). Furthermore, post-transcriptional editing of a minor
fraction of the GlyR3 mRNA at a single nucleotide position
has been reported to result in a gain-of-function receptor (27).
This editing reaction leads to the substitution of proline 185
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with leucine in the ECD and increases the apparent agonist
affinity of 3-GlyRs.
Structure of the GlyR and Its Extracellular Binding Sites
An atomic resolution structure of a GlyR is not available yet
despite efforts to obtain suitable amounts of purified protein for
structural studies (28). Therefore, structural information has
been inferred from other Cys loop receptors or bacterial
homologs of the group I LGIC family. Electronmicroscopy data
collected from the muscle-type nAChR from Torpedo (29) and
the coordinates of the acetylcholine-binding protein AChBP, a
soluble homopentameric protein that is structurally homolo-
gous to the ECDof group I LGICs (30), have beenwidely used to
model the ECD ofmany different receptors, including the GlyR
(9, 31, 32). Recently, the first crystal structure of an anion-con-
ducting Cys loop receptor, the glutamate-gated channel
(GluCl) from Caenorhabditis elegans, was solved at atomic res-
olution (33). GluCl is a close homolog (up to 43% sequence
identity) (supplemental Fig. S1) of GlyR subunits and also con-
tains their hallmark feature, the conserved disulfide bridge in
loop C. Therefore, GluCl-based models of GlyRs, as shown in
Fig. 1, are considered highly reliable templates for ligand bind-
ing studies and the rational design of novel selective drugs.
Agonists and competitive antagonists are known to bind to
the ECDat the interfaces of two adjacent subunits (4, 5, 22). The
GlyR binding pocket is formed by distinct “loop regions” of the
principal () and complementary () subunit surfaces (Fig. 2).
Residues whose substitution affects agonist and antagonist
binding have been identified in loops D, B, E, and C (4, 5, 31). In
addition, the disulfide bond between 1Cys-198 and 1Cys-
209 constraining loop C appears to be critical for both cell sur-
face expression and ligand binding (34). The binding determi-
nants of the  subunit are less well studied; two GlyR residues
(Arg-86 and Glu-180, equivalent to 1Arg-65 and 1Glu-157,
respectively) (Fig. 2) have been found to influence ligand bind-
ing to heteromeric 1-GlyRs (9). Docking of the agonist gly-
cine and the antagonist strychnine into homologymodels of the
1-1 and 1- interfaces resulted in complex structures that
agreed well with previous mutational data (9). However, the
properties of the - interface had remained enigmatic, as
GlyR alone does not form functional channels. A novel
mutagenesis strategy guided by homology modeling has
recently allowed reproduction of all potential agonist-binding
sites (-, -, and -) present in heteromeric GlyRs by sin-
gle-subunit expression (35). Although fully functional, the
resulting - binding site displayed the most distinct pharma-
cological profile toward a range of agonists and modulators
tested, indicating that it might be selectively targeted to modu-
late the activity of synaptic GlyRs.
The ECD of GlyRs binds not only agonists and competitive
antagonists but also compounds that allosterically modulate
the agonist responses of different LGICs. Neurosteroids, gen-
eral anesthetics, and ethanol potentiate GlyR currents, whereas
the divalent cation Zn2, tropeines, and endogenous cannabi-
noids, such as anandamide and 2-arachidonylglycerol, have
both potentiating (at low concentrations) and inhibitory (at
high concentrations) effects. Because of their potential thera-
peutic importance, the binding sites and isoform selectivity of
thesemodulators have been intensely investigated (4, 5, 31, 36),
and their in vivo roles have been studied in transgenic and
knock-in mouse models (37, 38). Zn2 and tropeines bind
within or in the vicinity of the extracellular agonist-binding
sites (39, 40). In contrast, hydrophobic modulators, such as
neurosteroids and endocannabinoids (41) and anesthetics and
ethanol (42), all appear to act by binding to the transmembrane
domain (see below), although residues located in the ECD
and/or the large intracellular loop may also contribute to cur-
rent modulation (43, 44). Additionally, the principal excitatory
transmitter glutamate has been reported to allosterically poten-
tiate native and recombinant GlyRs; this may be important for
balancing excitation and inhibition in the CNS (45).
GlyR Chloride Channel
The transmembrane domain of GlyR subunits and other
group I LGICs consists of a four--helix bundle, in which the
transmembrane segments are arranged in a clockwise order
due to multiple interactions between specific hydrophobic res-
idues that are essential for proper receptor assembly (46). TM1-
TM2 and TM2-TM3 are connected by short loops, whereas
TM3 is linked to TM4 by long intracellular loops that contain
phosphorylation and ubiquitination sites as well as binding
motifs for interacting proteins. The amphiphilic TM2 forms
the ion channel; to facilitate comparisons between different
LGICs, its residues are often numbered from 1 to 19, with
position 1 corresponding to the cytoplasmic N-terminal end
and residue 19 to the extracellular C-terminal end. Substituted
cysteine accessibility experiments disclosed thatGly-2, Thr-6,
FIGURE1.Structuresofhomomeric1- andheteromeric1-GlyRsmod-
eled using GluCl as a template. Left, 1-GlyR shown with five glycine and
ivermectin molecules each and a single picrotoxin molecule bound (ligands
depicted as van der Waals spheres). Right, unliganded heteromeric 1-GlyR
with the different interfaces indicated.
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and Arg-19 line the pore of the 1-GlyR (47). Additional pore-
lining residues were inferred by sequence comparison with
other LGICs and include Thr-7, Leu-9, Thr-10, Thr-13, Ser-
16, and Gly-17 (48). A model of the pore domain of GlyRs
based on the recently determined structure of GluCl confirms
thatmost of these residues are indeed facing the channel lumen
(supplemental Fig. S2).
Agonist binding to the ECD of GlyRs triggers the opening of
the anion-selective channel spanning the plasma membrane.
Extensive work on different LGICs has demonstrated that the
conformational changes within the five subunits induced upon
agonist binding are consistent with an allosteric transition
model that predicts rotational movements of the TM2 seg-
ments around about position 9 (29). This model was recently
validated by comparing the structures of two bacterial LGIC
homologs crystallized in the open and closed states, respec-
tively (49) and is likely to similarly apply to the GlyR. Residues
located at the ends or outside of TM2 have been shown to
participate in the gating process, such as the GlyR1 residues
Arg-271, located in theM2-M3 linker (34), and Lys-276, a pore-
facing residue at the extracellular end of TM2 (50). Presumably,
these and other residues that reside at the interface between the
ECD and transmembrane domain are essential for coupling the
conformational changes occurring in the ECD upon agonist
binding to channel opening (4, 5, 51).
The GlyR channel is largely anion-selective but has been
reported to also permeate Na and K ions, albeit at low effi-
ciency (52). GlyRs display a permeability sequence of SCN 
NO3  I  Br Cl, which is inversely correlated to the
hydration energies of these ions, implying that removal of
hydration water molecules facilitates ion permeation (53). A
“ring of charges,” consisting of arginine residues (Arg-0) in
TM2, is thought to concentrate permeating chloride ions and to
repel oppositely charged cations. Consistent with this view, the
subunits of cation-conducting nAChRs have a negatively
charged residue (Glu-1) at the equivalent position, and a
respective substitution (A1E) was found to convert the GlyR
into a cation-selective receptor (52). Residues located at the
extracellular ends of the TM2 segments and in the adjacent
loops (Arg-19 and Lys-24) provide additional rings of charge,
whose substitution also reduced the unitary Cl conductance
(54). Besides these positively charged residues, a conserved pro-
line at position 2 appears to play an important role in deter-
mining the selectivity and functional properties of homomeric
GlyR channels (55); its deletion increased the pore size of the
1-GlyR and reduced its anion/cation permeability ratio (56).
The new GluCl structure shows that this proline residue is
located at the narrowest point of the channel and thus directly
restricts ion flow (supplemental Fig. S2).
The GlyR channel is blocked by a number of non-competi-
tive antagonists, such as picrotoxin, ginkgolide B, and cyanotri-
phenyl borate (4, 5). Previous mutagenesis data had indicated
that picrotoxin occludes the channel by binding to pore-ex-
posed residues of TM2 (57), although other sites of interaction
have also been proposed (58, 59). More recently, Pro-2 and
Thr-6 of TM2 were found to constitute important determi-
nants of picrotoxin block (60). The crystal structure obtained
from the GluCl-picrotoxin complex confirmed this assignment
by showing that these residues constitute the binding site for
this open channel blocker (33). Furthermore, it supports the
idea that the low inhibitory potency of picrotoxin observed at
heteromeric compared with homomeric GlyRs (57) is due to
steric hindrance by the bulky Phe-282 side chain extending
from TM2 of GlyR (Fig. 3).
Several hydrophobic modulators of the GlyR are thought to
interact with external sites of the transmembrane domain (42,
61). These include neurosteroids, general anesthetics, and alco-
hols, which all potentiateGlyR function (31). Earlymutagenesis
experiments had identified a common intrasubunit binding site
for these compounds in both GlyRs and GABAARs (42), which,
because of its predicted size and shape, was termed “big cavity”
(62).Within this cavity, the polar residues Ser-267 andThr-264
located in TM2 and TM3 were shown to influence the enhanc-
ing effect of volatile anesthetics and high dose ethanol in GlyRs
(42). Recently, the crystal structures of complexes between a
bacterial LGIC ortholog from Gloeobacter violaceus (GLIC)
and two anesthetics (propofol and desflurane) have been solved
(63). These structures nicely confirmed the concept of a com-
mon intrasubunit binding site in group I LGICs, which pre-
exists in the GLIC apo structure in the upper part of the trans-
membrane domain of each monomer and recruits anesthetics
FIGURE 2.Models of the principal () and complementary () surfaces of
the GlyR1 and GlyR agonist-binding regions. In heteromeric GlyRs,
the and surfaces of the 1 and  subunit ECDs generate non-equivalent
agonist-binding sites at the-,-, or- interface,which are all functional.
Note the significant sequence divergence (up to eight substitutions)
between 1 and , in particular within loop C.
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via van derWaal interactions. This bindingmay displace crucial
lipids and thereby positively or negatively influence channel
gating (63). In addition to the big cavity, a second intramem-
brane site located at the interfaces between adjacent subunits
appears to be crucial for potentiation by hydrophobic modula-
tors. The existence of an intersubunit binding site for general
anesthetics was first shown inGABAARs by photoaffinity label-
ing with etomidate (64). In GlyRs, this site is targeted by the
antihelminthic ivermectin, which allosterically activates both
GlyR and GluCl currents. The recent crystal structure of the
GluCl-ivermectin complex (33) delineates ivermectin bound at
the interface between TM3 from the principal () and TM1
from the complementary () subunits (Fig. 1). Furthermore, it
shows that ivermectin stabilizes the open state of GluCl by
inducing conformational changes in both the transmembrane
domain and ECD. Although most of the ivermectin-binding
residues of GluCl appear to be conserved in GlyRs, the GlyR
binding site for ivermectin has been suggested to differ (65) and
hence should be further challenged experimentally.
Roles of GlyR Isoforms in theMammalian CNS
The physiological functions of the different GlyR isoforms
have been incompletely analyzed due to the lack of subtype-
specific antagonists. Our present picture of GlyR subtypes is
based primarily on immunocytochemical studies and the anal-
ysis of knock-out mice.
1-GlyRs—GlyRs containing the 1 subunit represent the
predominant adult GlyR isoform, and heteromeric 1 recep-
tors account for the majority of synaptically localized GlyRs in
themammalian CNS. The importance of the GlyR1 subunit is
underlined by the existence of various disease mutations in the
Glra1 genes of different mammalian species, including mouse,
cattle, and human (5). The spasmodicmouse carries a substitu-
tion at position 52 (A52S) of Glra1 that reduces the agonist
binding affinity (66, 67). The oscillator strain constitutes a nat-
ural Glra1 null mutation due to a microdeletion in exon 8 that
truncates the 1 subunit after TM3 (68). Notably, GlyR func-
tion of the oscillatorpolypeptide can be rescuedupon coexpres-
sion of a C-terminal fragment containing TM4 (69). This result
and complementation experiments with different GlyR and
5-HT3 receptor fragments (46) have revealed an essential role of
TM interactions in group I LGIC assembly.
Upon recombinant expression, the GlyR1 subunit forms
channels characterized by short mean open times and fast
decay kinetics, as found for glycinergic spontaneous inhibitory
postsynaptic currents (sIPSCs) in adult spinal cord neurons
(70). In retinas from oscillator mice, glycinergic sIPSCs in
A-type ganglion cells are strikingly reduced and their kinetics
slowed due to Glra1 inactivation (71). Together, the available
data indicate that theGlyR1 subunit defines receptors that are
crucial for fast regulation of both motor and sensory functions.
2-GlyRs—This GlyR isoform is highly expressed at the
embryonic and neonatal stages but postnatally is largely
replaced by 1 subunit-containing receptors. Synaptically
localized 2 staining has been detected in different adult CNS
regions, including the spinal cord, brainstem, midbrain, olfac-
tory bulb, and retina, and corresponds to heteromeric 2
receptors (72). At early developmental stages, GlyR2 forms
homo-oligomeric receptors (73), which are extrasynaptically
localized and thought to mediate non-synaptic tonic transmis-
sion caused by non-vesicular glycine release and/or spillover
from adjacent nerve terminals.
Despite the availability ofGlra2/mice (74, 75), the precise
physiological roles of GlyR2 are still largely enigmatic because
the knock-out animals are phenotypically normal. Electro-
physiological recordings of neonatal GlyRs in spinal neurons
(70) and glycinergic sIPSCs in narrow-field amacrine cells of
Glra2/ mice (74) indicate that 2-GlyRs mediate IPSCs
characterized by slow decay kinetics. In Glra2/mice, recep-
tive field center responses in the retinal on and off pathways are
impaired (76), and hyperalgesia induced by the injection of
zymosan is prolonged compared with wild-type littermates
(77). Both its known sites of expression and the available phys-
iological data suggest that, in adult mammals, synaptic GlyR2
is involved mainly in regulating sensory pathways.
3-GlyRs—Originally, GlyR3 was considered a minor adult
GlyR isoform with an expression pattern resembling that of
GlyR1 (14, 78). In the spinal cord, GlyR3 staining is found at
synaptic sites in laminae I and II of the dorsal horn, where it
FIGURE 3. Transmembrane domains of homo- and heteromeric GlyRs. Left, picrotoxin bound in the chloride channel of the homomeric 1-GlyR. Binding
determinants include five Pro-250 and Thr-258 residues each. Right, in the 1-GlyR, three of the Thr-258 residues are replaced by Phe-282, and three of the
Pro-250 residues by Ala-274 of the  subunit. These substitutions explain the50-fold lower affinity of picrotoxin for heteromeric GlyRs.
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inhibits the propagation of nociceptive signals to higher brain
regions and serves as molecular substrate of pain sensitization
by the inflammatory mediator prostaglandin E2 (PGE2) (79).
PGE2 binds to prostaglandin EP2 receptors and thereby acti-
vates protein kinase A, which phosphorylates GlyR3 and thus
down-regulates glycine currents in dorsal horn neurons. In
Glra3/ mice, this down-regulation of glycine inhibition by
PGE2 is abolished, and PGE2 fails to sensitize pain responses
(79). Also, the analgesic effect of cannabinoids inmousemodels
of chronic inflammatory and neuropathic pain is absent in
Glra3/ animals (80). Hence, GlyR3 constitutes a promising
target for the development of novel drugs for the treatment of
chronic pain syndromes.
GlyR3 immunoreactivity has also been detected in other
pathways involved in sensory processing. In retina, GlyR3 is
localized at synapses that are distinct from GlyR1-containing
ones (71). By analyzingGlra3/mice, amacrine cells of theAII
subtype have been shown to contain synaptic 3-GlyRs, which
confer medium-fast kinetics on sIPSCs (74). These receptors
regulate the receptive fields of ON-ganglion cells by enhancing
the excitatory center response (76). Furthermore, GlyR3 has
been found at inhibitory synapses in the inner ear (81).
Together, the available data indicate that like GlyR2,
3-GlyRs have an important role in sensory information
processing.
4-GlyRs—GlyR4 is the least understood subtype of the
GlyR family; this mainly reflects the low abundance of 4
mRNA and protein in the mammalian CNS. In chicken
embryos, GlyR4 transcripts have been detected in the spinal
cord, peripheral ganglia, and male genital ridge (82). In the
adult rodent retina, GlyR4-immunoreactive synapses have
been found on displaced ON-cholinergic amacrine cells (71).
Upon heterologous expression, 4-GlyRs form channels with
pharmacological properties largely resembling those of 1
receptors (82). Notably, in humans, the GLRA4 gene is a pseu-
dogene. Based on the analysis of sIPSCs in narrow-field ama-
crine cells ofGlra2/mice, 4 receptors have been suggested
to display ultra-slow decay kinetics (74).
GlyR Subunit—The Glrb gene encodes the rodent  sub-
unit, which is present three times in adult pentameric 1-
GlyRs (9, 10). By in situ hybridization, high levels of GlyR
mRNA have been detected throughout the embryonic and
postnatal CNS (78). However, this widespread transcription of
Glrb is not reflected in a corresponding abundance of the 
protein. A recently generated monoclonal antibody revealed
GlyR immunoreactivity exclusively at GlyR-positive synapses
but not in CNS regions lacking glycinergic neurons, such as the
cortex (72). This discrepancy between GlyR transcript and
protein levels likely reflects a retention and rapid degradation in
the endoplasmic reticulum of GlyR in the absence of  sub-
units. Immunostainings of adultmouse retina have confirmed a
high extent (90%) of co-localization of GlyRwith GlyR1–3
(72). In the case of GlyR4, however, immunoreactive synapses
that lack GlyR staining were found in the inner plexiform
layer. Thus, aminor subpopulation of synaptic GlyRsmight not
be heteromeric.
The functional importance of GlyR is underlined by the
spasticmutation inmice, which produces a phenotype identical
to that seen in spasmodic animals (83). Spastic animals express
reduced levels of the major adult GlyR isoform 1 due to an
intronic insertion of a LINE-1 element in theGlrb gene (84, 85).
Causative for the reduced expression is exon skipping resulting
from a polymorphism of a splice signal amplified by the LINE-1
insertion (86).
Developmental Changes in GlyR Function and Isoform
Expression
In contrast to its hyperpolarizing action on adult neurons,
glycine depolarizes motor neurons during embryonic develop-
ment and around birth (87). Due to high intracellular chloride
concentrations at these stages, GlyR channel opening leads to
chloride efflux and thereby may induce neuronal firing,
although inhibition also may occur as a result of the shunting
conductance produced by GlyR activation. A depolarizing
excitatory function of GlyRs at early developmental stages may
be important for synaptogenesis because GlyR-triggered acti-
vation of voltage-gated Ca2 channels appears to be crucial for
GlyR clustering at postsynaptic sites (88). Also, it may be essen-
tial for the regulation of glutamate release by presynaptic GlyRs
that have been detected electrophysiologically in large adult
nerve terminals, such as the calyx ofHeld (89) and hippocampal
mossy fiber terminals (90). Postnatally, the neuronal chloride
equilibrium potential shifts to negative values due to chloride
extrusion upon expression of the K/Cl cotransporter KCC2
(91). Thus, GlyR currents become hyperpolarizing, i.e.
inhibitory.
In the spinal cord and brainstem, the developmental change
in GlyR function described above is paralleled by changes in
subunit composition (92). Embryonic and neonatal GlyRs are
thought to be extrasynaptically localized homopentamers of2
subunits (73), whereas adult synaptic GlyRs are heteromers
containing1 (or other) and subunits (7, 20). This change in
subunit composition alters the biophysical properties of GlyR
currents, resulting in faster decay kinetics and a smaller channel
conductance (70, 93). Recombinant 2-GlyRs show slower
response kinetics and larger subconductance state distribu-
tions than 1 receptors, consistent with the in vivo properties
of neonatal versus adult GlyRs (94). Apparently, the postnatal
change in GlyR subunit composition fine-tunes inhibitory
transmission by shortening the mean channel open time and
accelerating the decay of glycinergic IPSCs.
Mutations in Human GlyR Genes Cause Hyperekplexia
Mutations affecting glycinergic neurotransmission cause the
hereditary neuromotor disorder hyperekplexia (HKPX; startle
disease). The hallmark symptoms of this genetically heteroge-
neous disorder are an exaggerated startle response to auditory
or tactile stimuli and, particularly in neonates, transientmuscle
rigidity (“stiff baby syndrome”). In 1993, positional cloning dis-
closedmutations in theGLRA1 gene localized on chromosome
5q33.1 (termed theHKPX1 locus) as a major cause of hyperek-
plexia (95). In this pioneering study, substitutions of the highly
conserved residue Arg-271 within the extracellular loop con-
necting TM2 and TM3 were found in four families with auto-
somal dominant hyperekplexia. These substitutions decrease
the agonist sensitivity and single-channel conductance of
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recombinant GlyR1 (54, 96). Subsequently, additional domi-
nant and recessive inheritance patterns and compound
heterozygosity have been described for other patient families in
which various GLRA1 missense or null mutations have been
identified (4, 5, 97). Someof thesemutations have been found to
affect GlyR intracellular trafficking rather than agonist binding
or channel gating (69, 98). Consistent with an important role of
the  subunit in postsynaptic GlyR function, mutations in the
GLRB gene have been associated with HKPX2 (97, 99). A third
major form of hyperekplexia of presynaptic origin (HKPX3) is
due to mutations in the gene encoding the neuronal glycine
transporter GlyT2 (SLC6A5) (97).
Recent studies have implicated other GlyR genes, in particu-
lar GLRA3, in the pathology of other neurological disorders,
such as autism, human immunodeficiency virus-associated
dementia, generalized epilepsy, and amyotrophic lateral sclero-
sis (4, 5). Furthermore, autoantibodies against GlyR1 have
been found in patients suffering from progressive encephalo-
myelitis with rigidity and myoclonus (100). Together, all of
these studies underline the importance of properGlyR function
for human health.
Conclusion and Perspectives
Since its purification in 1982, considerable progress has been
made in elucidating the structure and pharmacology of the
GlyR and in identifying physiological functions of its distinct
isoforms. Furthermore, mouse models for different GlyR sub-
unit deficiencies have become available, and the importance of
GlyR mutations for the pathogenesis of human neuromotor
disease is now well understood. However, many unanswered
questions await further investigation, including the precise
mechanism of GlyR channel gating, the individual roles of the
different GlyR isoforms in various normal and diseased brain
regions, and the development of isoform-specific ligands.
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